Last reviewed · How we verify

NCT05556980: TLDG

Totally Laparoscopic Distal Gastrectomy for Gastric Cancer

Completed NA Last updated 25 September 2024
What this trial tests

NA trial testing totally laparoscopic distal gastrectomy in Postoperative Complications in 120 participants. Completed in 31 December 2023.

Timeline
1 September 2021
Primary endpoint
31 December 2023
31 December 2023

Quick facts

Lead sponsorLiu Liu
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment120
Start date1 September 2021
Primary completion31 December 2023
Estimated completion31 December 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Liu Liu

Who can join

Adults 18 to 80, male only, with Postoperative Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was designed as a randomized clinical trial comparing the totally laparoscopic distal gastrectomy with laparoscopy-assisted distal gastroectomy for patients with gastric cancer, in terms of short-term and long-term outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Postoperative Complications

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05556980.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing